Persistent Spinal Pain Syndrome Type II (PSPS T2)
Conditions
Brief summary
The primary endpoint is to observe whether there is a difference in the ODI score in patients with chronic lower back pain 12 months after an intervention focusing on pain relief for axial problems between the three arms. A longitudinal mixed model analysis will be used with timepoints defined at baseline, 1 month, 3 months, 6 months, and 12 months after the intervention.
Interventions
DRUGCatapressan 150 microgrammes /1 ml solution injectable/solution pour perfusion
DRUGOxyNorm Instant 5 mg
DRUGcomprimés orodispersibles
DRUGOxyNorm Instant 10 mg
DRUGLibroxar 8 mg / 2 mg comprimés sublinguaux
DRUGLibroxar 2 mg/0.5 mg Sublingualtabletten
DRUGCatapressan 150 microgrammes comprimés
DRUGOxyNorm Instant 20 mg
Sponsors
Vrije Universiteit Brussel
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is to observe whether there is a difference in the ODI score in patients with chronic lower back pain 12 months after an intervention focusing on pain relief for axial problems between the three arms. A longitudinal mixed model analysis will be used with timepoints defined at baseline, 1 month, 3 months, 6 months, and 12 months after the intervention. | — |
Countries
Belgium
Outcome results
None listed